Approvals/TGA/LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 20mg/10mL Liposome Injection concentrate glass vial

Approved

STANDARD

LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 20mg/10mL Liposome Injection concentrate glass vial

Sun Pharma ANZ Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 167ab37c5359007c
Product Name: LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 20mg/10mL Liposome Injection concentrate glass vial
Artg Id: 202826
Artg Name: LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 20mg/10mL Liposome Injection concentrate glass vial
Sponsor: Sun Pharma ANZ Pty Ltd
Company Detail Path: /organization/sun-pharma-anz-pty-ltd
Artg Date: 2013-12-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/3458e12c073249339288653f86fc3f70.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/8997476f89fa3e35f1735824cd95180e.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

167ab37c5359007c

Type

Standard